Home > Insider Trading > Filing (0001493152-23-046389)

Filing Details

Accession Number:: 0001493152-23-046389
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-12-28 17:00:21
Reporting Period:: 2023-12-26

Accepted Time:: 2023-12-28 17:00:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1603207	Notable Labs Ltd.	NTBL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1776703	Fr Capital Holdings, L.p.	2400 Market Street, Suite 237 Philadelphia PA 19103		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares, Par Value Nis 0.35 Each	Disposition	2023-12-26	11,456	$2.16	978,022	No	4	S	Indirect	See Footnote
Ordinary Shares, Par Value Nis 0.35 Each	Disposition	2023-12-27	20,033	$2.08	957,989	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

FR Capital Holdings, L.P. (the "Reporting Person") is the investment manager to First Round Capital V, LP, a Delaware limited partnership ("FRCV"), and First Round Capital VIII-F, LP, a Delaware limited partnership ("FRCVIIIF"). Josh Kopelman and William Trenchard are the managing members of the Reporting Person. As of December 28, 2023, FRCV held 391,621 ordinary shares, par value NIS 0.35 each ("Ordinary Shares") of Notable Labs, Ltd. and FRCVIIIF held 566,368 Ordinary Shares. The Reporting Person's and Messrs. Kopelman and Trenchard's beneficial ownership is limited to their pecuniary interest, if any, in such securities.
On December 26, 2023, FRCV sold 4,247 Ordinary Shares and FRCVIIIF sold 7,209 Ordinary shares, each at a weighted average price of $2.1618 per share. These shares were sold in multiple transactions at prices ranging from $2.05 to $2.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
On December 27, 2023, FRCV sold 7,426 Ordinary Shares and FRCVIIIF sold 12,607 Ordinary shares, each at a weighted average price of $2.0813 per share. These shares were sold in multiple transactions at prices ranging from $1.9893 to $2.1665, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.